JP2006519823A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519823A5 JP2006519823A5 JP2006505920A JP2006505920A JP2006519823A5 JP 2006519823 A5 JP2006519823 A5 JP 2006519823A5 JP 2006505920 A JP2006505920 A JP 2006505920A JP 2006505920 A JP2006505920 A JP 2006505920A JP 2006519823 A5 JP2006519823 A5 JP 2006519823A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- pharmaceutical composition
- composition according
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0305149.7A GB0305149D0 (en) | 2003-03-07 | 2003-03-07 | Compounds for the treatment of pain |
| PCT/GB2004/000935 WO2004078183A1 (en) | 2003-03-07 | 2004-03-05 | Compounds for the treatment of pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519823A JP2006519823A (ja) | 2006-08-31 |
| JP2006519823A5 true JP2006519823A5 (https=) | 2011-06-02 |
Family
ID=9954247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006505920A Pending JP2006519823A (ja) | 2003-03-07 | 2004-03-05 | 疼痛治療のための化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7759321B2 (https=) |
| EP (1) | EP1603577B1 (https=) |
| JP (1) | JP2006519823A (https=) |
| KR (1) | KR20050115273A (https=) |
| CN (1) | CN100579533C (https=) |
| AT (1) | ATE401087T1 (https=) |
| AU (1) | AU2004216889B2 (https=) |
| CA (1) | CA2514098A1 (https=) |
| CY (1) | CY1108416T1 (https=) |
| DE (1) | DE602004015085D1 (https=) |
| DK (1) | DK1603577T3 (https=) |
| ES (1) | ES2310288T3 (https=) |
| GB (1) | GB0305149D0 (https=) |
| NO (1) | NO20054476L (https=) |
| NZ (1) | NZ541521A (https=) |
| PL (1) | PL1603577T3 (https=) |
| PT (1) | PT1603577E (https=) |
| SI (1) | SI1603577T1 (https=) |
| WO (1) | WO2004078183A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0228723D0 (en) * | 2002-12-09 | 2003-01-15 | Cambridge Biotechnology Ltd | Treatment of pain |
| GB0305153D0 (en) * | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Identification of therapeutic compounds |
| GB0305150D0 (en) * | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Use of therapeutic compounds |
| US20080221060A1 (en) * | 2004-03-05 | 2008-09-11 | Martyn Pritchard | Therapeutic Compounds |
| PE20060272A1 (es) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a |
| GB0426394D0 (en) * | 2004-12-01 | 2005-01-05 | Health Prot Agency | Fusion proteins |
| US8603779B2 (en) | 2004-12-01 | 2013-12-10 | Syntaxin, Ltd. | Non-cytotoxic protein conjugates |
| US8399400B2 (en) * | 2004-12-01 | 2013-03-19 | Syntaxin, Ltd. | Fusion proteins |
| US8778634B2 (en) | 2004-12-01 | 2014-07-15 | Syntaxin, Ltd. | Non-cytotoxic protein conjugates |
| US8512984B2 (en) | 2004-12-01 | 2013-08-20 | Syntaxin, Ltd. | Non-cytotoxic protein conjugates |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| CN1947717B (zh) * | 2005-10-14 | 2012-09-26 | 卓敏 | 选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用 |
| GB0610867D0 (en) | 2006-06-01 | 2006-07-12 | Syntaxin Ltd | Treatment of pain |
| AU2007263728A1 (en) | 2006-06-27 | 2008-01-03 | Biovitrum Ab (Publ) | Adenosine derivatives for the treatment of pain |
| BRPI0713902A2 (pt) | 2006-06-27 | 2012-11-27 | Biovitrum Ab | compostos terapêuticos |
| US7906518B2 (en) | 2006-06-27 | 2011-03-15 | Cbt Development Limited | Therapeutic compounds |
| US20140056870A1 (en) | 2012-08-27 | 2014-02-27 | Allergan, Inc. | Fusion proteins |
| CN103342727A (zh) * | 2013-07-01 | 2013-10-09 | 淮海工学院 | 一种2-甲氧基腺苷的合成方法 |
| JP6440240B2 (ja) * | 2014-02-19 | 2018-12-19 | 国立大学法人富山大学 | 末梢神経障害誘発感覚異常を改善する外用剤 |
| EP4003984A1 (en) * | 2019-07-31 | 2022-06-01 | Sea4Us - Biotecnologia e Recursos Marinhos, Lda. | Nitenin analogue compounds and their use in the treatment of chronic and acute pain |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE792155A (fr) | 1971-12-01 | 1973-05-30 | Takeda Chemical Industries Ltd | Nouveaux derives de l'adenosine et leur procede de production |
| JPS4861498A (https=) | 1971-12-01 | 1973-08-28 | ||
| DE2359536C2 (de) | 1972-12-08 | 1984-08-02 | Takeda Chemical Industries, Ltd., Osaka | 2,6-Diaminonebularinderivate |
| JPS5461194A (en) | 1977-10-21 | 1979-05-17 | Takeda Chem Ind Ltd | Preparation of n22substituted 2*66diaminonebularin |
| JPS5461195A (en) | 1977-10-21 | 1979-05-17 | Takeda Chem Ind Ltd | N2-substituted phenyl-2,6-diaminonebularin |
| US4705758A (en) | 1984-06-19 | 1987-11-10 | Warner-Lambert Company | Adenosine receptor assay and kit |
| US5677290A (en) * | 1990-05-10 | 1997-10-14 | Fukunaga; Atsuo F. | Therapeutic use of adenosine compounds as surgical anesthetics |
| US5679650A (en) * | 1993-11-24 | 1997-10-21 | Fukunaga; Atsuo F. | Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine |
| US5683989A (en) * | 1993-12-17 | 1997-11-04 | Novo Nordisk A/S | Treatment of ischemias by administration of 2,N6 -substituted adenosines |
| JPH09512823A (ja) * | 1994-05-10 | 1997-12-22 | サンド・リミテッド | アデノシン誘導体 |
| US5877180A (en) | 1994-07-11 | 1999-03-02 | University Of Virginia Patent Foundation | Method for treating inflammatory diseases with A2a adenosine receptor agonists |
| IT1275420B (it) | 1995-06-02 | 1997-08-05 | Schering Plough S P A | Metodo per misurare l'affinita' di legame al recettore a2a dell'adenosina di componenti di interesse farmacologico mediante l'uso del ligando triziato (3h)-sch 58261 |
| CA2317093A1 (en) | 1998-01-08 | 1999-07-15 | Joel M. Linden | A2a adenosine receptor agonists |
| GB0228723D0 (en) * | 2002-12-09 | 2003-01-15 | Cambridge Biotechnology Ltd | Treatment of pain |
| GB0305153D0 (en) | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Identification of therapeutic compounds |
-
2003
- 2003-03-07 GB GBGB0305149.7A patent/GB0305149D0/en not_active Ceased
-
2004
- 2004-03-05 DK DK04717707T patent/DK1603577T3/da active
- 2004-03-05 ES ES04717707T patent/ES2310288T3/es not_active Expired - Lifetime
- 2004-03-05 CN CN200480004454A patent/CN100579533C/zh not_active Expired - Fee Related
- 2004-03-05 PT PT04717707T patent/PT1603577E/pt unknown
- 2004-03-05 JP JP2006505920A patent/JP2006519823A/ja active Pending
- 2004-03-05 KR KR1020057016699A patent/KR20050115273A/ko not_active Ceased
- 2004-03-05 NZ NZ541521A patent/NZ541521A/en unknown
- 2004-03-05 WO PCT/GB2004/000935 patent/WO2004078183A1/en not_active Ceased
- 2004-03-05 EP EP04717707A patent/EP1603577B1/en not_active Expired - Lifetime
- 2004-03-05 AT AT04717707T patent/ATE401087T1/de not_active IP Right Cessation
- 2004-03-05 CA CA002514098A patent/CA2514098A1/en not_active Abandoned
- 2004-03-05 AU AU2004216889A patent/AU2004216889B2/en not_active Ceased
- 2004-03-05 PL PL04717707T patent/PL1603577T3/pl unknown
- 2004-03-05 US US10/547,455 patent/US7759321B2/en not_active Expired - Fee Related
- 2004-03-05 DE DE602004015085T patent/DE602004015085D1/de not_active Expired - Lifetime
- 2004-03-05 SI SI200430876T patent/SI1603577T1/sl unknown
-
2005
- 2005-09-27 NO NO20054476A patent/NO20054476L/no not_active Application Discontinuation
-
2008
- 2008-10-15 CY CY20081101141T patent/CY1108416T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006519823A5 (https=) | ||
| JP2011132229A5 (https=) | ||
| CN100579533C (zh) | 治疗疼痛的化合物 | |
| JP4836454B2 (ja) | 疼痛、特に痛覚過敏治療のための、スポンゴシン（２−メトキシアデノシン）の使用。 | |
| JP2006514638A5 (https=) | ||
| JP2017522352A5 (https=) | ||
| EP1621195A3 (en) | The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury | |
| AU2007337089A1 (en) | Alpha-2B receptor agonist and anticonvulsant compositions for treatng chronic pain | |
| JP2021008496A (ja) | インドール化合物を用いた疼痛又は間質性膀胱炎の治療方法 | |
| RU2013157928A (ru) | Терапевтические средства для регуляции уровня фосфора в сыворотке | |
| ES2311537T3 (es) | Utilizacion de nefiracetam en el tratamiento de la neurodegeneracion postquemica. | |
| JPWO2019225740A1 (ja) | インドール化合物を含む多発性硬化症の治療又は予防剤 | |
| ES2270981T3 (es) | Procedimiento de tratamiento de la neurodegeneracion. | |
| JP2010536827A (ja) | ある種の炎症性障害の治療に有用なカルボニルアミノ誘導体 | |
| CN116688135B (zh) | 一种骨关节炎药物治疗组合物及其制备方法和应用 | |
| JP2023545788A (ja) | ジヒドロオロト酸デヒドロゲナーゼ（ｄｈｏｄｈ）阻害剤による自己免疫疾患の治療 | |
| JP6857619B2 (ja) | Ｎ−［７−［（メチルスルホニル）アミノ］−４−オキソ−６−フェノキシ−４ｈ−１−ベンゾピラン−３−イル］ホルムアミドまたはその塩を含有する医薬組成物 | |
| EA008927B1 (ru) | Применение производных 2h-[1,3]оксазино[3,2-a]индола для лечения невропатической боли | |
| JP5699030B2 (ja) | エタネルセプトを含む線維筋痛症の治療剤 | |
| US20100179176A1 (en) | V3 antagonists for the treatment or prevention of chronic pain | |
| HK1087629B (en) | Compounds for the treatment of pain | |
| CN1809356A (zh) | 吲唑衍生物用于治疗神经病性疼痛的用途 | |
| CN114845722A (zh) | 化合物在预防和/或治疗强直性脊柱炎中的应用和相应的组合物 | |
| Soliman et al. | 25 patientsRamiKarroum | |
| JPWO2007049732A1 (ja) | 関節リウマチの予防及び／又は治療法 |